Inovio Pharmaceuticals INO
NASDAQ INO
$1.16 -0.05 (-4.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2011 - 2026)

Updated

Inovio Pharmaceuticals (INO) posted Return on Assets [ROA] of -156.22% for Q2 2026, down 37.29 percentage points from -118.93% a year earlier and down 24.58 percentage points from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Inovio Pharmaceuticals' Return on Assets [ROA] came in at -90.03%, down 14.14 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -41.04 percentage points (FY2020 to FY2025).
  • In prior years, Inovio Pharmaceuticals' Return on Assets [ROA] was -75.88% in FY2024 (-23.86 pp), -52.02% in FY2023 (+14.25 pp), -66.27% in FY2022 (-7.63 pp) and -58.64% in FY2021 (-9.65 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q3 2011.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last ten quarters, with an average year-over-year change of -25.63 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2023, with a gain of 10.49 percentage points; the weakest was Q2 2022, with a drop of 55.18 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -131.63% (Q1 2026), -117.47% (Q4 2025) and -126.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Inovio Pharmaceuticals 94.68 Mn 94.68 Mn - -156.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -156.22%
Mar 31, 2026 -131.63%
Dec 31, 2025 -117.47%
Sep 30, 2025 -126.27%
Jun 30, 2025 -118.93%
Mar 31, 2025 -101.65%
Dec 31, 2024 -97.89%
Sep 30, 2024 -94.08%
Jun 30, 2024 -92.04%
Mar 31, 2024 -83.07%
Dec 31, 2023 -74.23%
Sep 30, 2023 -77.24%
Jun 30, 2023 -67.42%
Mar 31, 2023 -78.49%
Dec 31, 2022 -74.99%
Sep 30, 2022 -77.55%
Jun 30, 2022 -77.91%
Mar 31, 2022 -69.29%
Dec 31, 2021 -58.87%
Sep 30, 2021 -39.21%
API Access

Inovio Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INO&period=max&api_key=YOUR_API_KEY